Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07445074 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AI-Based Mobile Intervention on Medication Non-Adherence and Transition

StatusRecruiting
PhaseNot applicable
Started2026-05
View on ClinicalTrials.gov ↗

Amendment history

2026-05-27
Study Status, Conditions, Contacts/Locations v2
Study sites2 entries, revised
Orlando Health Arnold Palmer Hospital UniversityOrlando ofHealth CentralOrlando FloridaRegional Medical Center
2026-04-27
Study Status, Sponsor/Collaborators, Contacts/Locations v1
Start date2026-03→2026-05
Study sites1→2
Collaborators+95 characters
American Epilepsy Society Orlando Regional Medical Center Orlando Health Arnold Palmer Hospital
2026-03-02
Original filing
This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA. Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.
Trial Details
NCT Number NCT07445074
Lead Sponsor University of Central Florida
Collaborators: American Epilepsy Society, Orlando Regional Medical Center, Orlando Health Arnold Palmer Hospital
Conditions Epilepsy, Seizure
Enrollment 200 participants
Start Date 2026-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-29